| Literature DB >> 27486393 |
Luanda A Collange Grecco1, Claudia Santos Oliveira2, Manuela Galli3, Camila Cosmo4, Natália de Almeida Carvalho Duarte2, Nelci Zanon5, Dylan J Edwards6, Felipe Fregni7.
Abstract
The current priority of investigations involving transcranial direct current stimulation (tDCS) and neurorehabilitation is to identify biomarkers associated with the positive results of the interventions such that respondent and non-respondent patients can be identified in the early phases of treatment. The aims were to determine whether: (1) present motor evoked potential (MEP); and (2) injuries involving the primary motor cortex, are associated with tDCS-enhancement in functional outcome following gait training in children with cerebral palsy (CP). We reviewed the data from our parallel, randomized, sham-controlled, double-blind studies. Fifty-six children with spastic CP received gait training (either treadmill training or virtual reality training) and tDCS (active or sham). Univariate and multivariate logistic regression analyses were employed to identify clinical, neurophysiologic and neuroanatomic predictors associated with the responsiveness to treatment with tDCS. MEP presence during the initial evaluation and the subcortical injury were associated with positive effects in the functional results. The logistic regression revealed that present MEP was a significant predictor for the six-minute walk test (6MWT; p = 0.003) and gait speed (p = 0.028), whereas the subcortical injury was a significant predictor of gait kinematics (p = 0.013) and gross motor function (p = 0.021). In this preliminary study involving children with CP, two important prediction factors of good responses to anodal tDCS combined with gait training were identified. Apparently, MEP (integrity of the corticospinal tract) and subcortical location of the brain injury exerted different influences on aspects related to gait, such as velocity and kinematics.Entities:
Keywords: cerebral palsy; gait training; motor evoked potential; neuromodulation; non-invasive brain stimulation
Year: 2016 PMID: 27486393 PMCID: PMC4949210 DOI: 10.3389/fnhum.2016.00361
Source DB: PubMed Journal: Front Hum Neurosci ISSN: 1662-5161 Impact factor: 3.169
Clinical and demographic variables according to injured area (cortical and subcortical) and presence or absence of motor evoked potential (MEP) at baseline assessment.
| Injury location | Motor evoked potential | |||||
|---|---|---|---|---|---|---|
| Cortical | Subcortical | Present | Absent | |||
| 23 | 33 | – | 29 | 27 | – | |
| Age (years)* | 8.1 (1.7) | 7.5 (1.9) | 0.48 | 8.0 (2.0) | 7.8 (2.1) | 0.71 |
| Active tDCS | 7.3 (1.6) | 7.1 (1.1) | 0.23 | 7.6 (1.6) | 7.9 (1.9) | 0.75 |
| Sham tDCS | 7.5 (1.8) | 7.8 (1.1) | 0.76 | 8.1 (1.3) | 7.6 (2.2) | 0.81 |
| GMFCS (I/II/III)** | 1/10/12 | 4/13/16 | 0.51 | 3/14/12 | 2/9/16 | 0.46 |
| Active tDCS | 0/5/5 | 3/10/10 | 0.48 | 1//10/8 | 1/4/9 | 0.47 |
| Sham tDCS | 1/5/7 | 1/3/6 | 0.91 | 2/4/4 | 1/5/7 | 0.94 |
| Hemiparetic/Diparetic** | 2/21 | 3/30 | 0.92 | 4/25 | 1/26 | 0.80 |
| Active tDCS | 1/9 | 2/21 | 0.40 | 3/16 | 1/13 | 0.41 |
| Sham tDCS | 1/12 | 1/9 | 0.84 | 1/9 | 0/13 | 0.37 |
| 6MWT (m)* | 252.4 (62.7) | 241.4 (70.2) | 0.54 | 261.3 (98.4) | 249.9 (80.2) | 0.45 |
| Active tDCS | 242.3 (25.1) | 250.5 (57.8) | 0.98 | 261.2 (20.6) | 242.3 (25.1) | 0.30 |
| Sham tDCS | 227.9 (40.8) | 251.0 (49.9) | 0.06 | 249.4 (43.3) | 227.7 (40.8) | 0.25 |
| Gait speed (m/s)* | 0.58 (0.17) | 0.55 (0.12) | 1.0 | 0.61 (0.13) | 0.54 (0.12) | 0.04 |
| Active tDCS | 0.54 (0.07) | 0.57 (0.05) | 0.53 | 0.55 (0.06) | 0.54 (0.007) | 0.05 |
| Sham tDCS | 0.51 (0.16) | 0.48 (0.11) | 0.03 | 0.48 (0.07) | 0.48 (0.06) | 0.08 |
| Gait profile score (°)* | 11.3 (2.1) | 12.1 (2.9) | 0.23 | 11.9 (3.1) | 11.2 (1.7) | 0.30 |
| Active tDCS | 11.8 (0.6) | 11.5 (1.0) | 0.06 | 11.2 (0.5) | 11.2 (0.6) | 0.28 |
| Sham tDCS | 11.3 (0.6) | 11.3 (1.0) | 0.61 | 10.9 (0.6) | 10.9 (0.7) | 0.33 |
| MEP (mV)* | 1.5 (0.5) | 1.6 (0.4) | 0.42 | 1.6 (0.7) | – | – |
| Active tDCS | 0.9 (0.6) | 0.8 (0.7) | 0.78 | 1.3 (0.2) | – | – |
| Sham tDCS | 0.7 (0.4) | 0.7 (0.6) | 0.93 | 1.2 (0.3) | – | – |
| Active tDCS (%) | 10 (43.7%) | 23 (69.6%) | 19 (65.5%) | 14 (51.8%) | ||
Legend: GMFCS, gross motor function classification system; tDCS, transcranial direct current stimulation; 6MWT (m), six-minute walk test; MEP, motor evoked potential. *Data expressed as mean and standard deviation. Analyses performed with unpaired t-test. **Numbers indicate frequency (n) of children in each group. Analyses performed with Chi-square.
Results of linear logistic regressions in the active and sham tDCS groups.
| Active tDCS | Sham tDCS | |||||||
|---|---|---|---|---|---|---|---|---|
| Variables | Respondent (Yes/No) | B (SE) | Exp (B) | Respondent (Yes/No) | B (SE) | Exp (B) | ||
| 6MWT | ||||||||
| MEP present | 19/0 | 2.5 (0.86) | 8.9 | 0.003 | 5/4 | 0.9 (0.76) | 0.4 | 0.400 |
| Subcortical injury | 18/5 | 2.6 (0.93) | 8.0 | 0.004 | 6/4 | 0.8 (0.38) | 0.6 | 0.664 |
| Gait velocity | ||||||||
| MEP present | 16/3 | 1.6 (0.77) | 4.8 | 0.028 | 3/6 | 0.8 (0.90) | 2.4 | 0.331 |
| Subcortical injury | 10/13 | 1.1 (0.80) | 1.8 | 0.170 | 6/4 | 0.8 (0.76) | 0.4 | 0.384 |
| Gait profile score | ||||||||
| MEP present | 10/9 | 1.0 (0.74) | 1.9 | 0.168 | 4/5 | 1.7 (1.30) | 0.1 | 0.172 |
| Subcortical injury | 17/6 | 2.1 (0.85) | 6.1 | 0.013 | 4/6 | 1.2 (1.12) | 0.3 | 0.281 |
| GMFM dimension E | ||||||||
| MEP present | 11/8 | 1.0 (0.73) | 2.1 | 0.147 | 3/6 | 2.0 (1.30) | 0.1 | 0.120 |
| Subcortical injury | 15/8 | 1.9 (0.84) | 5.3 | 0.021 | 7/3 | 1.2 (0.73) | 0.4 | 0.479 |
Respondent (Yes/No) shows the frequency of children considered responders to intervention with MEP present (active tDCS: 19 and sham tDCS: 9 children) and subcortical injury (active tDCS: 23 and sham tDCS: 10 children). Legend: SD, standard deviation; B, B coefficient; SE, standard error of B coefficient; Exp (B), measurement of likelihood ratio of association between predictor variable and outcome. *p < 0.05.
Mean and SD of results in children with presence and absence of MEP, and subcortical and cortical lesions considering active and sham tDCS.
| MEP present | MEP absent | Subcortical injury | Cortical injury | |||||
|---|---|---|---|---|---|---|---|---|
| Active | Sham | Active | Sham | Active | Sham | Active | Sham | |
| 6MWT (m) | ||||||||
| Pre-intervention | 261.2 (20.6) | 249.4 (43.3) | 242.3 (25.1) | 227.7 (40.8) | 250.5 (57.8) | 251.0 (49.9) | 241.5 (28.3) | 212.1 (43.9) |
| Post-intervention | 418.2 (60.8)* | 310.1 (11.8) | 366.9 (41.3) | 331.1 (47.1) | 393.9 (62.4)# | 339.0 (54.4) | 345.3 (40.5) | 317.6 (79.5) |
| Follow-up | 393.8 (58.2) | 286.8 (92.2) | 356.9 (47.9) | 305.3 (50.3) | 354.2 (62.1) | 322.2 (42.9) | 338.4 (53.8) | 287.4 (56.3) |
| Gait speed (m/s) | ||||||||
| Pre-intervention | 0.55 (0.06) | 0.48 (0.07) | 0.54 (0.07) | 0.48 (0.06) | 0.54 (0.11) | 0.51 (0.16) | 0.57 (0.05) | 0.48 (0.11) |
| Post-intervention | 0.82 (0.16)* | 0.56 (0.12) | 0.59 (0.08) | 0.56 (0.12) | 0.77 (0.18)# | 0.62 (0.19) | 0.68 (0.11) | 0.57 (0.10) |
| Follow-up | 0.71 (0.13) | 0.58 (0.06) | 0.56 (0.05) | 0.58 (0.06) | 0.70 (0.13) | 0.58 (0.24) | 0.63 (0.06) | 0.54 (0.14) |
| Gait profile score (%) | ||||||||
| Pre-intervention | 11.2 (0.5) | 10.9 (0.6) | 11.2 (0.6) | 10.9 (0.7) | 11.8 (0.6) | 11.3 (0.6) | 11.5 (1.0) | 11.3 (1.0) |
| Post-intervention | 8.8 (0.9)* | 9.2 (0.8) | 9.1 (1.1) | 9.1 (0.5) | 8.5 (1.2)# | 9.9 (0.6) | 10.4 (1.0) | 9.8 (1.4) |
| Follow-up | 9.8 (0.9) | 9.7 (1.0) | 9.7 (0.2) | 9.7 (0.8) | 9.4 (1.6)# | 10.0 (1.1) | 10.8 (1.1) | 10.3 (1.3) |
| GMFM-88 (dimension E) | ||||||||
| Pre-intervention | 53.9 (13.0) | 56.7 (8.6) | 52.1 (11.2) | 48.8 (12.4) | 52.0 (11.3) | 53.4 (19.9) | 51.6 (10.9) | 49.8 (13.8) |
| Post-intervention | 69.4 (14.4) | 76.3 (11.6) | 69.3 (9.7) | 62.8 (12.6) | 68.8 (13.7)# | 66.4 (10.5) | 63.7 (14.3) | 61.6 (16.8) |
| Follow-up | 66.2 (15.7) | 68.9 (10.6) | 64.1 (9.8) | 61.1 (14.4) | 63.8 (14.1) | 63.6 (8.2) | 57.1 (12.1) | 59.4 (15.9) |
| MEP (mV) | ||||||||
| Pre-intervention | 1.3 (0.2) | 1.2 (0.3) | – | – | 0.9 (0.6) | 0.7 (0.4) | 0.8 (0.7) | 0.7 (0.6) |
| Post-intervention | 2.3 (0.3) | 1.5 (0.4) | – | – | 1.5 (1.0) | 1.0 (0.9) | 1.4 (1.3) | 0.9 (0.8) |
| Follow-up | 1.6 (0.4) | 1.2 (0.5) | – | – | 1.0 (0.8) | 0.8 (0.5) | 1.0 (0.9) | 0.7 (0.6) |
| Resting motor threshold (rMT, %) | 57.9 (11.1) | 60.1 (13.2) | – | – | 52.6 (12.6) | 54.3 (13.5) | 58.8 (11.8) | 57.6 (12.5) |
Legend: GMFM, gross motor function measure. Analyses performed using analysis of variance (ANOVA) followed by Bonferroni post hoc test. *p < 0.05: analysis considering the groups: MEP present and active tDCS, MEP present and sham tDCS, MEP absente and active tDCS, MEP absent and sham tDCS. .
Figure 1Data for six-minute walk test (6MWT), gait speed, gait profile score and dimension E of the gross motor function measure (GMFM-88) during pre-intervention, post-intervention and follow-up evaluations considering motor evoked potential (MEP) present and absent as well as active and sham transcranial direct current stimulation (tDCS; 56 children). Children with MEP present at pre-intervention evaluation and who received active tDCS demonstrated better results at the post-intervention evaluation in comparison to other groups for 6MWT, gait speed and gait profile score. *p < 0.05 analysis of variance (ANOVA) followed by Bonferroni post hoc test.
Figure 2Data for 6MWT, gait speed, gait profile score and dimension E of the GMFM-88 during pre-intervention, post-intervention and follow-up evaluations considering subcortical and cortical injuries as well as active and sham tDCS groups (56 children). Children with subcortical injury and who received active tDCS presented better results at the post-intervention evaluation in comparison to other groups for all variables. This group also had better results regarding gait profile score at follow-up evaluation. *p < 0.05 ANOVA followed by Bonferroni post hoc test.